| Primary |
| Product Used For Unknown Indication |
36.6% |
| Uterine Leiomyoma |
14.1% |
| Menorrhagia |
7.0% |
| Prostate Cancer |
7.0% |
| Anaemia |
5.6% |
| Breast Cancer |
5.6% |
| Prophylaxis |
4.2% |
| Intervertebral Disc Protrusion |
2.8% |
| Abdominal Pain Upper |
1.4% |
| Adenomyosis |
1.4% |
| Cardiovascular Disorder |
1.4% |
| Dyslipidaemia |
1.4% |
| Dysmenorrhoea |
1.4% |
| Endometriosis |
1.4% |
| Gastric Ulcer |
1.4% |
| Gastrointestinal Disorder |
1.4% |
| Infection Prophylaxis |
1.4% |
| Ovarian Cyst |
1.4% |
| Precocious Puberty |
1.4% |
| Preoperative Hormone Treatment |
1.4% |
|
| Carpal Tunnel Syndrome |
12.5% |
| Cerebral Infarction |
8.3% |
| Subarachnoid Haemorrhage |
8.3% |
| Visual Field Defect |
8.3% |
| Abscess |
4.2% |
| Brain Neoplasm |
4.2% |
| Cerebral Vasoconstriction |
4.2% |
| Dermatitis Contact |
4.2% |
| Granuloma |
4.2% |
| Interstitial Lung Disease |
4.2% |
| Jaundice |
4.2% |
| Leukaemia |
4.2% |
| Microscopic Polyangiitis |
4.2% |
| Neck Pain |
4.2% |
| Posterior Reversible Encephalopathy Syndrome |
4.2% |
| Right Ventricular Failure |
4.2% |
| Thrombotic Cerebral Infarction |
4.2% |
| Toxic Skin Eruption |
4.2% |
| White Blood Cell Count Increased |
4.2% |
|
| Secondary |
| Prostate Cancer |
33.3% |
| Respiratory Tract Infection |
11.9% |
| Prophylaxis |
9.9% |
| Drug Use For Unknown Indication |
6.0% |
| Benign Prostatic Hyperplasia |
4.4% |
| Product Used For Unknown Indication |
4.4% |
| Metastases To Bone |
4.0% |
| Breast Cancer |
3.2% |
| Uterine Leiomyoma |
3.2% |
| Breast Cancer Metastatic |
2.8% |
| Gastritis |
2.8% |
| Hypertension |
2.8% |
| Menorrhagia |
2.4% |
| Dwarfism |
1.6% |
| Dysuria |
1.6% |
| Breast Cancer Recurrent |
1.2% |
| Endometriosis |
1.2% |
| Ovarian Cyst |
1.2% |
| Preoperative Hormone Treatment |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
|
| Carpal Tunnel Syndrome |
9.8% |
| Hepatic Function Abnormal |
9.8% |
| Interstitial Lung Disease |
9.8% |
| Respiratory Tract Infection |
9.8% |
| Cerebral Infarction |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Breast Cancer Male |
3.9% |
| Metastases To Bone |
3.9% |
| Microscopic Polyangiitis |
3.9% |
| Muscular Weakness |
3.9% |
| Oedema |
3.9% |
| Osteonecrosis |
3.9% |
| Pyrexia |
3.9% |
| Renal Failure Acute |
3.9% |
| Sinusitis |
3.9% |
| Weight Decreased |
3.9% |
| White Blood Cell Count Increased |
3.9% |
| Brain Neoplasm |
2.0% |
| Diffuse Alveolar Damage |
2.0% |
| Disseminated Intravascular Coagulation |
2.0% |
|
| Concomitant |
| Prostate Cancer |
38.5% |
| Prophylaxis |
12.0% |
| Metastases To Bone |
8.9% |
| Hypertension |
5.0% |
| Drug Use For Unknown Indication |
3.8% |
| Prostate Cancer Metastatic |
3.3% |
| Constipation |
2.8% |
| Multiple Myeloma |
2.7% |
| Breast Cancer |
2.5% |
| Product Used For Unknown Indication |
2.3% |
| Breast Cancer Recurrent |
2.0% |
| Cancer Pain |
2.0% |
| Dysuria |
2.0% |
| Gastritis |
2.0% |
| Prostate Cancer Recurrent |
2.0% |
| Pain |
1.8% |
| Premedication |
1.7% |
| Acute Lymphocytic Leukaemia |
1.5% |
| Benign Prostatic Hyperplasia |
1.5% |
| Gastric Ulcer |
1.5% |
|
| Interstitial Lung Disease |
16.5% |
| White Blood Cell Count Decreased |
9.9% |
| Cardiac Failure |
6.6% |
| Pneumonia |
6.6% |
| Hepatic Function Abnormal |
5.5% |
| Prostate Cancer |
5.5% |
| Tooth Extraction |
5.5% |
| Toothache |
5.5% |
| Malaise |
4.4% |
| Purulent Discharge |
4.4% |
| Hypocalcaemia |
3.3% |
| Hypophosphataemia |
3.3% |
| Liver Disorder |
3.3% |
| Pancytopenia |
3.3% |
| Pneumocystis Jiroveci Pneumonia |
3.3% |
| Pyrexia |
3.3% |
| Sepsis |
3.3% |
| Back Pain |
2.2% |
| Breast Cancer Male |
2.2% |
| Lung Neoplasm Malignant |
2.2% |
|
